Results 151 to 160 of about 20,916 (244)
Defining the tumor microenvironment of non‐small cell lung cancer
The tumor microenvironment (TME) in non‐small cell lung cancer is highly heterogeneous, both at a patient level and tumor microenvironment resolution. Defining the tumor microenvironment from patient‐responders and non‐responders will aid in the development of targeted therapeutics specific for each individual patient.
Kidane Siele Embaye +5 more
wiley +1 more source
Review on heavy ion radiotherapy facilities and related ion sources
Heavy ion radiotherapy awakens worldwide interest recently. The clinical results obtained by the Heavy Ion Medical Accelerator in Chiba at the National Institute of Radiological Sciences in Japan have clearly demonstrated the advantages of carbon ion radiotherapy. Presently, there are four facilities for heavy ion radiotherapy in operation, and several
openaire
Rice bran–derived neutral EQRPR (L‐Glu‐L‐Gln‐L‐Arg‐L‐Pro‐L‐Arg) pentapeptide was structurally and biologically characterized using DFT calculations, vibrational spectroscopy, molecular docking, and molecular dynamics simulations. The DFT/wb97xd/6–31++G(d,p) level of theory showed the best agreement with the experimental spectra.
Gozde Yilmaz +3 more
wiley +1 more source
Corrigendum: A comparative study of two in vivo PET verification methods in clinical cases
Junyu Zhang +24 more
doaj +1 more source
Reconstruction techniques in nuclear medicine time-of-flight PET [PDF]
Vandenberghe, Stefaan
core +1 more source
Corrigendum to 'Lazertinib with stereotactic body radiotherapy in oligometastatic EGFR-mutant non-small-cell lung cancer': [ESMO Open. Volume 11, Issue 2, February 2026, 106057]. [PDF]
Lee JB +13 more
europepmc +1 more source
Combined carbon ion radiotherapy and immunotherapy: leveraging the immunological advantages of carbon ion. [PDF]
Chen R +6 more
europepmc +1 more source
Factors requiring adaptive re-planning in carbon ion radiotherapy for head and neck cancers. [PDF]
Yamada T +6 more
europepmc +1 more source
Development of heavy-ion radiotherapy facility in Japan
Heavy-ion beams are very suitable for deeply-seated cancer treatment not only owing to their high dose localization around the Bragg peak, but also owing to the high biological effect there. NIRS, therefore, constructed HIMAC as the world’s first heavy-ion accelerator facility dedicated to medical use.
openaire

